Search

Your search keyword '"Hosoda, Chiaki"' showing total 31 results

Search Constraints

Start Over You searched for: Author "Hosoda, Chiaki" Remove constraint Author: "Hosoda, Chiaki"
31 results on '"Hosoda, Chiaki"'

Search Results

1. Quantification of escape from X chromosome inactivation with single-cell omics data reveals heterogeneity across cell types and tissues

2. DOCK2 is involved in the host genetics and biology of severe COVID-19

3. The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force

4. Outcomes of EGFR tyrosine kinase inhibitors and immune checkpoint inhibitors for advanced EGFR-mutated non-small cell lung cancer

6. DOCK2 is involved in the host genetics and biology of severe COVID-19

7. Frequency and Significance of Coinfection in Patients with COVID-19 at Hospital Admission

9. Japan COVID-19 Task Force: a nation-wide consortium to elucidate host genetics of COVID-19 pandemic in Japan

10. A retrospective analysis of pembrolizumab plus chemotherapy versus pembrolizumab monotherapy for advanced or recurrent non‐small cell lung cancer

14. Outcome and risk factor of immune‐related adverse events and pneumonitis in patients with advanced or postoperative recurrent non‐small cell lung cancer treated with immune checkpoint inhibitors

15. Predictors of Severe COVID-19 Pneumonia

16. Antibody Response as Assessed by A Rapid Immunochromatographic Assay in Patients with COVID-19 Pneumonia Caused by the Novel Coronavirus, SARS-CoV-2

17. IgG antibody seroconversion and the clinical progression of COVID-19 pneumonia: A retrospective, cohort study

19. A case of invasive pulmonary aspergillosis diagnosed by transbronchial lung biopsy during treatment for diabetic ketoacidosis in a type 1 diabetic patient

20. Clinical course and findings of 14 patients with COVID-19 compared with 5 patients with conventional human coronavirus pneumonia

21. DOCK2is involved in the host genetics and biology of severe COVID-19

23. Pleuritis associated with primary Sjogren syndrome

24. Pulmonary alveolar proteinosis developing during steroid treatment in a patient with organizing pneumonia in association with atypical chronic myeloid leukemia

26. Outcome and risk factor of immune‐related adverse events and pneumonitis in patients with advanced or postoperative recurrent non‐small cell lung cancer treated with immune checkpoint inhibitors.

27. Pleuritis associated with primary Sjogren syndrome.

28. Promising Effect of Crizotinib on Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer in an Elderly Patient with a Poor Performance Status: A Case Report and Literature Review

30. Infection Presenting as an Endobronchial Polyp and Upper Lobe Atelectasis.

31. [Clinical characteristics of pulmonary Mycobacterium avium complex infection complicated with lung cancer].

Catalog

Books, media, physical & digital resources